Aberrant Upregulation of 14-3-3σ and EZH2 Expression Serves as an Inferior Prognostic Biomarker for Hepatocellular Carcinoma

PLoS ONE - United States
doi 10.1371/journal.pone.0107251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)